Full text is available at the source.
Abstract
Aerobic exercise may enhance the clearance of β-amyloid from the brain through the aquaporin 4 (AQP4) protein.
- There are currently no effective drug therapies for Alzheimer's disease (AD).
- Aerobic exercise has been shown to have time-sensitive benefits in the prevention and treatment of AD.
- AQP4 is involved in the glymphatic system that clears interstitial solutes, including β-amyloid, from the brain.
- Voluntary exercise has been demonstrated to promote glymphatic clearance function in mice.
- Glymphatic function decreases in mid- to late-stage AD due to loss of AQP4 polarity distribution.
- AQP4-mediated glymphatic clearance may be critical for the efficacy of aerobic exercise in treating AD.
Simplified